Arkolith/Insider Trading/RLMD/Form 4

Traversa Sergio

Chief Executive Officer, DirectorRELMADA THERAPEUTICS, INC. (RLMD) · full profile →Form 4 · filed Jan 31, 2024
Net Buying
Open-Market Buys
$387K
Open-Market Sells
$0
Net Open-Market Flow
$387K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 31, 2024Buy(P)27K$4.00$110K244K
Jan 30, 2024Buy(P)41K$3.90$160K217K
Jan 29, 2024Buy(P)32K$3.71$117K176K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-008560) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML